Market Place
Sourcing Support
Medicus SkinJect Ph2 Shows 80% ORR With KOL Validation
30 Mar 2026 //
GLOBENEWSWIRE
Medicus Pharma: 80% ORR in Phase 2 SkinJect, Unveils AI Platform
26 Mar 2026 //
GLOBENEWSWIRE
Medicus Pharma To Present Skinject(R) Phase 2 Results
18 Mar 2026 //
PHARMIWEB
Medicus Pharma Announces SkinJect Phase 2 Data Review
16 Mar 2026 //
GLOBENEWSWIRE
Medicus Pharma Interprets Positive Skinject Phase 2 Data
09 Mar 2026 //
GLOBENEWSWIRE
Medicus Pharma Unveils SkinJect Phase 2 at Biotech Showcase 2026
05 Jan 2026 //
GLOBENEWSWIRE
Medicus Pharma Files FDA Priority Voucher For SKNJCT-003
17 Nov 2025 //
PHARMIWEB
Medicus Pharma Teams Up With Gorlin Syndrome Alliance
29 Oct 2025 //
GLOBENEWSWIRE
Medicus Pharma Receives FDA Type C Meeting Feedback For Skinject
29 Sep 2025 //
PHARMAWEB
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.